课题基金 / 基金详情

Optogenetic Tools for Minimally Invasive Therapies

Optogenetic Tools for Minimally Invasive Therapies
用于微创治疗的光遗传学工具
批准号:
1264975
负责人:
Brian Chow
金额:
$42.55万
依托单位:
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-01 至 2017-01-31

项目摘要

项目成果

Brian Chow的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1264975ChowThe ability to rationally convert a microbial opsin pump into a channel would validate a fundamental hypothesis in ion channel structure-function, which states that a key difference between a pump and a channel is the existence of a gate that prevents backflow of ions by passive conductance and enables active ion translocation against large gradients. This biophysical feat of rational conversion by protein engineering would be the first of its kind. Furthermore, while the activity-dependent safety of neural silencing by proton and chloride pumps has been evaluated in the literature, the creation of optogenetic reagents specifically for the purpose of activity-dependent safety is novel. Moreover, the translationally focused goal of engineering a calcium-free channelrhodopsin to reduce risk of excito-toxicity is in fact opposite to ongoing efforts in the field, which seek to augment calciumconductance to increase sensitivity. The creation of reagents, whose molecular properties are tailored for translational purposes, would represent a new direction in optogenetic reagent development, which to date have focused on pushing the limits of microbial opsin photocurrent magnitude, kinetics, and spectral properties.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CAREER: Establishing novel signaling transmission modes of LOV photoreceptors
  • 批准号:
    1652003
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $50.0万
  • 财政年份:
    2017
  • 负责人:
    Brian Chow
  • 依托单位:
海外基金